|
biomedicina slovenica |
"Dopamine" : 325
-
Sočan Vesna; Kržan Mojca
The uptake of [3H]dopamine into cultured neonatal rat astrocytes involves multiple transporters
2022 ►
-
Zobec Lea; Zajc Irena; Sočan Vesna; Kržan Mojca; Žiberna Lovro
Effect of selected drug compounds on dopamine cytotoxicity on human endothelial cells and rat astrocytes
2022 ►
-
Šalamon Arčan Iris; Kouter Katarina; Videtič Paska Alja
Depressive disorder and antidepressants from an epigenetic point of view
2022 ►
-
Umek Nejc
The effects of biologically important divalent and trivalent metal cations on the cyclization step of dopamine autooxidation reaction
2022 ►
-
Redenšek Trampuž Sara; Kristanc Tilen; Blagus Tanja; Trošt Maja; Dolžan Vita
Genetic variability of the vitamin D receptor affects susceptibility to Parkinson's disease and dopaminergic treatment adverse events
2022 ►
-
Redenšek Sara; Kristanc Tilen; Blagus Tanja; Trošt Maja; Dolžan Vita
Genetska variabilnost receptorja za vitamin D vpliva na dovzetnost za parkinsonovo bolezen in pojav neželenih učinkov dopaminergičnega zdravljenja
2022 ►
-
Zupan Amadea
Depresija in prehrana
[Depression and nutrition]
2022 ►
-
Kolmančič Kaja; Živin Marko; Zorović Maja
Modulation by estradiol of L-dopa-induced dyskinesia in a rat model of post-menopausal hemiparkinsonism
2022 ►
-
Žabkar Ines; Zorović Maja
Učinki estrogena na profil izražanja genov v dopaminsko denervirani možganski hemisferi
2020 ►
-
Redenšek Sara; Trošt Maja; Dolžan Vita
Effects of genetic variability in dopaminergic pathway on treatment response in Parkinson's disease
2018 ►
-
Redenšek Sara; Trošt Maja; Dolžan Vita
Genetic variability in oxidative stress pathways influences the occurrence of adverse events of dopaminergic treatment in Parkinson's disease
2018 ►
-
Redenšek Sara; Blagus Tanja; Trošt Maja; Dolžan Vita
Serotonin-related functional genetic variants affect the occurrence of psychiatric and motor adverse events of dopaminergic treatment in Parkinson’s disease
2022 ►
-
Tsermpini Evangelia Erini; Redenšek Sara; Dolžan Vita
Genetic factors associated with tardive dyskinesia
2022 ►
-
Assimakopoulos Konstantinos; Karaivazoglou Katerina; Skokou Maria; Kalogeropoulou Marina; Kolios Panagiotis; Gourzis Philippos; Patrinos George P.; Tsermpini Evangelia Erini
Genetic variations associated with sleep disorders in patients with schizophrenia
2018 ►
-
Korecka Joanna A.; Moloney Elizabeth B.; Eggers Ruben; Hobo Barbara; Scheffer Sanny; Ras-Verloop Nienke; Pasterkamp R. Jeroen; Swaab Dick Frans; Smit August B.; Van Kestere Ronald E.
Repulsive guidance molecule a (RGMa) induces neuropathological and behavioral changes that closely resemble Parkinson's disease
2017 ►
-
Fang Qiuyuan; Xicoy Helena; Shen Junqing; Luchetti Sabina; Dai Di; Zhou Pei; Qi Xin-Rui; Martens Gerard J.M.; Huitinga Inge; Swaab Dick Frans
Histamine-4 receptor antagonist ameliorates Parkinson-like pathology in the striatum
2021 ►
-
Schulte Eva C.; Altmaier Elisabeth; Berger Hannah S.; Trinh Do Kieu; Kastenmüller Gabi; Wahl Simone; Adamski Jerzy; Peters Annette; Krumsiek Jan; Suhre Karsten
Alterations in lipid and inositol metabolisms in two dopaminergic disorders
2016 ►
-
Zorović Maja; Kolmančič Kaja; Živin Marko
Effects of L-dopa on expression of prolactin and synaptotagmin IV in 17[beta]-estradiol-induced prolactinomas of ovariectomized hemiparkinsonian rats
2021 ►
-
Ramos-Gonzalez Paula; Mato Susana; Chara Juan Carlos; Verkhratsky Alexei; Matute Carlos; Cavaliere Fabio
Astrocytic atrophy as a pathological feature of Parkinson's disease with LRRK2 mutation
2021 ►
-
Hartleben Goetz; Schorpp Kenji; Kwon Yun; Betz Barbara; Tsokanos Foivos-Filippos; Dantes Zahra; Schäfer Arlett; Rothenaigner Ina; Manuel José; Adamski Jerzy
Combination therapies induce cancer cell death through the integrated stress response and disturbed pyrimidine metabolism
2021 ►
-
Ferlan Aleksandra; Sket Dušan
Dopaminergična aktivnost [alfa]-ergozina in 2-Br-[alfa]-ergozina
1979 ►
-
Levstek Tina; Redenšek Sara; Trošt Maja; Dolžan Vita; Trebušak Podkrajšek Katarina
Assessment of the telomere length and its effect on the symptomatology of Parkinson's disease
2021 ►
-
Pirc Marolt Tinkara; Kramar Barbara; Bulc Rozman Klara; Šuput Dušan; Milisav Irina
Aripiprazole reduces liver cell division
2020 ►
-
Blagotinšek Cokan Kaja; Mavri Maša; Rutland Catrin; Glisic Sanja; Sencanski Milan; Vrecl Milka; Kubale Valentina
Critical impact of different conserved endoplasmic retention mofits and dopamine receptor interacting proteins (DRIPs) on intracellular localization and trafficking of the D2 dopamine receptor (D2-R) isoforms
2020 ►
-
Redenšek Sara; Dolžan Vita
The role of pharmacogenomics in personalization of the Parkinson's disease treatment
2020 ►
-
Redenšek Sara; Jenko Bizjan Barbara; Trošt Maja; Dolžan Vita
Clinical and clinical-pharmacogenetic models for prediction of the most common psychiatric complications due to dopamingeric treatment in Parkinson's disease
2020 ►
-
Huber Eva Maria; Beyer Leonie; Prix Catharina; Schönecker Sonja; Palleis Carla; Rauchmann Boris-Stephan; Morbelli Silvia; Chincarini Andrea; Bruffaerts Rose; Vandenberghe Rik; Trošt Maja; Gregorič Kramberger Milica; Grmek Marko
Metabolic correlates of dopaminergic loss in dementia with lewy bodies
2020 ►
-
Rus Tomaž; Jamšek Jan; Berlot Rok; Šurlan Popović Katarina; Grmek Marko; Trošt Maja
Nuklearnomedicinske preiskave pri diagnosticiranju demence in parkinsonizmov
[Nuclear medicine investigations in dementia and parkinsonism]
2020 ►
-
Lavrin Teja; Konte Tilen; Kostanjšek Rok; Sitar Simona; Sepčić Kristina; Prpar Mihevc Sonja; Žagar Ema; Župunski Vera; Lenassi Metka; Rogelj Boris; Gunde-Cimerman Nina
The neurotropic black yeast Exophiala dermatitidis induces neurocytotoxicity in neuroblastoma cells and progressive cell death
2020 ►
-
Nettleton Jodi E.; Klančič Teja; Schick Alana; Choo Ashley C.; Shearer Janet; Borgland Stephanie L.; Chleil Faye; Mayengbam Shyamchand; Reimer Raylene A.
Low-dose Stevia (Rebaudioside A) consumption perturbs gut microbiota and the mesolimbic dopamine reward system
2019 ►
-
Schwarzlin Romina; Salam Sejjad; Pušenjak Nika
Balancing the apoptotic switch - from cancer to Parkinsonʼs disease
2017 ►
-
Redenšek Sara; Trošt Maja; Dolžan Vita
Genetic polymorphisms in dopaminergic pathway influence the occurrence of adverse events of dopaminergic treatment in Parkinson's disease
2019 ►
-
Redenšek Sara; Jenko Barbara; Trošt Maja; Dolžan Vita
Clinical-pharmacogenetic predictive models for time to occurrence of levodopa related motor complications in Parkinson's disease
2019 ►
-
Redenšek Sara; Flisar Dušan; Kojović Maja; Gregorič Kramberger Milica; Georgiev Dejan; Pirtošek Zvezdan; Trošt Maja; Dolžan Vita
Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease
2019 ►
-
Sikirić Predrag; Seiwerth Sven; Ručman Rudolf; Turkovic Branko; Stancic-Rokotov Dinko; Brcic Luka; Sever Marko; Klicek Robert; Radic Bozo; Kolenc Danijela
Stable gastric pentadecapeptide BPC 157
2011 ►
-
Sikirić Predrag; Seiwerth Sven; Ručman Rudolf; Kolenc Danijela; Batelja Vuletic Lovorka; Drmić Domagoj; Grgic Tihomir; Strbe Sanja; Zukanovic Goran; Crvenkovic Dalibor
Brain-gut axis and pentadecapeptide BPC 157
2016 ►
-
Iskra Vugdelija Lina; Kržan Mojca; Žiberna Lovro
Osnovne značilnosti privzema dopamina v astrocite novorojene podgane
2018 ►
-
Redenšek Sara; Flisar Dušan; Kojović Maja; Gregorič Kramberger Milica; Georgiev Dejan; Pirtošek Zvezdan; Trošt Maja; Dolžan Vita
Dopaminergic pathway genes influence adverse events related to dopaminergic treatment in Parkinson's disease
2019 ►
-
Pišlar Anja; Tratnjek Larisa; Glavan Gordana; Živin Marko; Kos Janko
Upregulation of cysteine protease cathepsin X in the 6-hydroxydopamine model of Parkinson's disease
2018 ►
-
Redenšek Sara; Trošt Maja; Dolžan Vita
The effect of inflammation-related genetic polymorphisms on the occurrence of non-motor adverse events of dopaminergic treatment in Parkinson's disease
2018 ►
-
Redenšek Sara; Trošt Maja; Dolžan Vita
Vpliv genetskih dejavnikov na izid dopaminergičnega zdravljenja Parkinsonove bolezni
2017 ►
-
Rektor Ivan; Bohnen Nicolaas I.; Korczyn Amos D.; Gryb Viktoria; Kumar Hrishikesh; Gregorič Kramberger Milica; de Leeuw Frank-Erik; Pirtošek Zvezdan; Rektorova Irena; Schlesinger Ilana
An updated diagnostic approach to subtype definition of vascular parkinsonism
2018 ►
-
Šet Vida; Šinkovec Jaka; Trošt Maja
Dopaminski disregulacijski sindrom pri bolnikih s Parkinsonovo bolezijo
[Dopamine dysregulation syndrome in Parkinson's disease patients]
2017 ►
-
Turčin Arijana; Dolžan Vita; Porcelli Stefano; Serretti Alessandro; Kores-Plesničar Blanka
Adenosine hypothesis of antipsychotic drugs revisited
2016 ►
-
Terzič Tea; Kastelic Matej; Dolžan Vita; Kores-Plesničar Blanka
Genetic polymorphisms in dopaminergic system and treatment-resistant schizophrenia
2016 ►
-
Bogićević Sanja; Živin Marko
Efficacy of potential atypical antipsychotic lek-8829 on behavioral effects in rat model of catalepsy and inhibition of amphetamine induced psychomotor stimulation
[[Učinkovitost potencialnega atipičnega antipsihotika lek-8829 na vedenjske učinke na podganjih modelih katalepsije ter z amfetaminom povzročene psihomotorične stimulacije]]
2015 ►
-
Tratnjek Larisa; Glavan Gordana; Višnjar Tanja; Živin Marko
Up-regulation and axonal transport of synaptotagmin-IV in the direct pathway medium spiny neurons in hemi-parkinsonian rats induced by dopamine D1 receptor stimulation
2016 ►
-
Dolžan Vita; Kores-Plesničar Blanka; Serretti Alessandro; Mandelli Laura; De Ronchi Diana; Olgiati Paolo; Zalar Bojan; Koprivšek Jure; Breskvar Katja
Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment
2006 ►
-
Huang Yu-Ting; Georgiev Dejan; Foltynie Tom; Limousin Patricia; Speekenbrink Maarten; Jahanshahi Marjan
Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions
2015 ►
-
Batagelj Nevenka; Jensterle Sever Mojca; Dolžan Vita
Genetska variabilnost dopaminergičnega sistema in izločanje inzulina ter metabolični odgovor na zdravljenje pri bolnicah s sindromom policističnih ovarijev
2015 ►
-
Štemberger Nastja; Tratnjek Larisa; Živin Marko
Dopaminergic modulation of synaptotagmin IV and substance P expression and characterization of striatal alterations during culture of organotypic whole brain slices from young rats
2015 ►
-
Kapraljević Ana; Tratnjek Larisa; Živin Marko
The effect of acute ibogaine treatment on the survival of dopaminergic neurons in organotypic nigrostriatal Co - cultures
2015 ►
-
Tratnjek Larisa; Glavan Gordana; Živin Marko
Dopaminergic modulation of synaptotagmin IV expression in animal model of Parkinson disease
2015 ►
-
Bajrović Fajko; Jugović Domagoj; Milutinović Živin Aleksandra; Glavan Gordana; Tratnjek Larisa; Glišović Špela; Saghafi Mehdi M.; Živin Marko
Synaptotagmin 4mRNA expression as an inducible indicator of dopaminergic hyperexcitation and of glutamatergic excitotoxicity
2015 ►
-
Rodríguez José J.; Noristani Harun N.; Verkhratsky Alexei
The serotonergic system in ageing and Alzheimer's disease
2012 ►
-
L'Episcopo F.; Tirolo C.; Testa N.; Caniglia S.; Morale M. C.; Cossetti M. C.; D'Adamo Patrizia; Zardini E.; Andreoni L.; Ihekwaba A. E. C.
Reactive astrocytes and Wnt/[beta]-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
2011 ►
-
Wilson Gabrielle R.; Sim Joe C. H.; McLean Catriona; Giannandrea Maila; Galea Charles A.; Riseley Jessica R.; Stephenson Sarah E. M.; Fitzpatrick Elizabeth; Haas Stefan A.; D'Adamo Patrizia
Mutations in RAB39B cause X-linked intellectual disability and early-onset parkinson disease with [alpha]-synuclein pathology
2014 ►
-
Locatelli Igor; Mrhar Aleš
Odmerjanje zdravil za zdravljenje Alzheimerjeve in Parkinsonove bolezni
[Dosage regimens of drugs used in the treatment of Alzheimer's and Parkinson's disease]
2008 ►
-
Devjak Rok; Fon Tacer Klementina; Juvan Peter; Virant-Klun Irma; Rozman Damjana; Vrtačnik-Bokal Eda
Cumulus cells gene expression profiling in terms of oocyte maturity in controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist
2012 ►
-
Rojc Žan; Komel Radovan; Videtič Paska Alja
Preiskava polimorfizmov v genu DRD2 pri žrtvah samomora
2014 ►
-
Kubale Valentina; Blagotinšek Kaja; Pogačnik Azra; Vrecl Milka
Vloga tretje znotrajcelične zanke pri regulaciji dolge oblike dopaminskega receptotja tipa 2 (D2L-R)
2011 ►
-
Rubio-Agusti Ignacio; Kojović Maja; Edwards Mark J.; Murphy Elaine; Chandrashekar Hoskote S.; Lachmann Robin H.; Bhatia Kailash P.
Atypical parkinsonism and cerebrotendinous xanthomatosis: report of a family with corticobasal syndrome and a literature review
2012 ►
-
Bologna Matteo; Kojović Maja
Interfacing basal ganglia models and Parkinson's disease phenomenology
2012 ►
-
Grgurevič Neža; Strle Drago; Trifković Mario; Majdič Gregor
Development of novel electrochemical biosensors for detection of neurotransmitters
2013 ►
-
Tratnjek Larisa; Glavan Gordana; Živin Marko
Dopaminergic modulation of striatalexpression of Synaptotagmin IV
2013 ►
-
Moretti Rita; Torre Paola; Antonello Rodolfo M.; Vidus Rosin Marta; Esposito Francesca; Rubelli Furman Matej; Bellini Giuseppe
Apathy
2012 ►
-
Groznik Vida; Guid Matej; Sadikov Aleksander; Možina Martin; Georgiev Dejan; Kragelj Veronika; Ribarič Samo; Pirtošek Zvezdan; Bratko Ivan
Elicitation of neurological knowledge with argument-based machine learning
2013 ►
-
Siedlinski Mateuzs; Cho Michael H; Bakke Per; Košnik Mitja
Genome-wide association study of smoking behaviours in patients with COPD
2011 ►
-
Blagotinšek Kaja; Kubale Valentina; Pogačnik Azra; Vrecl Milka
Identification of conserved motif in the third intracellular loop in dopamine receptor type 2 (D2L-R) related to intracellular retention of D2L-R
2012 ►
-
Ribarič Samo
The pharmacological properties and therapeutic use of apomorphine
2012 ►
-
Jukić Tomislav; Rojc Bojan; Boben-Bardutzky Darja; Hafner Mateja; Ihan Alojz
The use of a food supplementation with D-phenylalanine, L-glutamine and L-5-hydroxytriptophan in the alleviation of alcohol withdrawal symptoms
2011 ►
-
Šubic Ana; Steblovnik Tjaša
Vpliv kontinuirane dopaminergične stimulacije z ropinirolom na nemotorične simptome in kakovost življenja bolnikov s Parkinsonovo boleznijo
2011 ►
-
Trošt M; Starovasnik-Žagavec B; Tomše P; Čuš A; Slodnjak I; Vodušek D; Pirtošek Z
Cognitive and motor function correlation with brain activity in early Parkinson's disease and the effect of dopaminergic treatment
2011 ►
-
Šubic Ana; Steblovnik Tjaša
Vpliv kontinuirane dopaminergične stimulacije z ropinirolom na nemotorične simptome in kakovost življenja bolnikov s Parkinsonovo boleznijo
2010 ►
-
Tomše Petra; Starovasnik-Žagavec Barbara; Grmek Marko; Slodnjak Ivan; Čuš Anja; Vodušek David B; Pirtošek Zvezdan; Trošt Maja
Brain perfusion changes in Parkinson's disease: the effect of dopaminergic treatment
2011 ►
-
Pirtošek Zvezdan
Myths and realities of continuous dopaminergic stimulation
2011 ►
-
Kapoon R; Pirtošek Z; Frankel JP; Stern GM; Lees AJ; Bottomley JM; Haran NS
Treatment of Parkinson's disease with novel dopamine D2 agonist SK&F 101468
1989 ►
-
Ostrovršnik Jaka; Cvirn Anina; Peterlin-Mašič Lucija
Amfetamin in metamfetamin: mehanizem delovanja, učinki, zastrupitev in diagnostika
[Amphetamine and methamphetamine: mechanism of action, effects, poisoning and diagnostics]
2011 ►
-
Zaletel Marjan
Zdravljenje fibromialgije
[Treatment of fibromyalgia]
2010 ►
-
Živin Marko
Potential applications of dopamine D1 agonist and D2 antagonist LEK-8829
2010 ►
-
Gregorič Kramberger Ljudmila; Štukovnik Vita; Čuš Anja; Repovš Grega; Tomše Petra; Pečarič-Meglič Nuška; Garaševič Zdenko; Jensterle Jože; Pirtošek Zvezdan
Parkinson's disease dementia: clinical correlates of brain SPECT perfusion and treatment
2010 ►
-
Kobal J; Švigelj V; Mesec A; Pogačnik T
Unilateral spatial neglect after dopaminergic agonist treatment of patients with right hemisphere infarction
1996 ►
-
Kobal Jan
Early dopaminergic stimulation after an acute cerebral infarction
1990 ►
-
Križaj David
Mesopic state: cellular mechanisms involved in pre- and post-synaptic mixing of rod and cone signals
2000 ►
-
Križaj David; Akopian Abram; Witkovsky Paul
The effects of L-glutamate, AMPA, quisqualate, and kainate on retinal horizontal cells depend on adaptational state: implications for rod-cone interactions
1994 ►
-
Križaj David; Gabriel Robert; Owen Geoffrey W; Witkovsky Paul
Dopamine D2 receptor-mediated modulation of rod-cone coupling in the Xenopus retina
1998 ►
-
Križaj David; Copenhagen David R
Calcium regulation in photoreceptors
2002 ►
-
Witkovsky Paul; Gabriel Robert; Križaj David
Anatomical and neurochemical characterization of dopaminergic interplexiform processes in mouse and rat retinas
2008 ►
-
Trošt M; Šubic A; Steblovnik T; Kirbiš M
The effect of continuous dopaminergic stimulation with ropinirole on non-motor symptoms, quality of life and autonomic functions in Parkinson's disease patients
2010 ►
-
Pal Robert
Vpliv dopaminergične stimulacije na alternativno izrezovanje pre-mRNA sinaptotagmina 7 pri poskusnih podganah z normalno in s povečano dopaminergično odzivnostjo
2009 ►
-
Georgiev Dejan; Danieli Aljoša; Ocepek Lidija; Novak Dominika; Zupančič-Križnar Nina; Trošt Maja; Pirtošek Zvezdan
Othello syndrome in patients with Parkinson's disease
2010 ►
-
Sinkovič Andreja
Akutno srčno popuščanje pri bolnikih z akutnim srčnim infarktom - diagnoza, prognoza in zdravljenje
[Acute heart failure in patients with acute myocardial infarction - diagnosis, prognosis and treatment]
2009 ►
-
Mele Tina; Čarman-Kržan Marija; Jurič Damijana Mojca
Regulatory role of monoamine neurotransmitters in astrocytic NT-3 synthesis
2009 ►
-
Lainščak Mitja; Coletta Alison P; Sherwi Nasser; Cleland John G
Clinical trials update from the Heart failure society of America meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1
2009 ►
-
Pirtošek Z; Flisar D
Neuroprotection and dopamine agonists
2004 ►
-
Pirtošek Zvezdan
'Bad guys' among the antiparkinsonian drugs
2009 ►
-
Trošt Maja; Dhawan Vijay; Feigin Andrew; Eidelberg David
PET/SPECT
2005 ►
-
Starovasnik Barbara; Repovš Grega; Čuš Anja; Foster Erin; Vodušek David B
Prospective memory and dopaminergic therapy in early stage Parkinson's disease - a pilot study
2009 ►
-
Steblovnik Tjaša; Šubic Ana; Ručna Veronika; Kirbiš Mojca; Trošt Maja
The effect of continuous dopaminergic stimulation with ropinirole on non-motor symptoms and quality of life in patients with Parkinson's disease
2009 ►
-
Kores-Plesničar Blanka; Dolžan Vita; Serretti Alessandro; Mandelli Laura; Zalar Bojan
Polymorphisms in dopamine receptors genes and symptomatology in patients on maintenance antipsychotic therapy
2009 ►
1 101 201 301
Nova poizvedba
Pripombe
Na vrh strani
Inštitut za biostatistiko in medicinsko informatiko